当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析

翰宇药业

(300199)

  

流通市值:110.18亿  总市值:137.79亿
流通股本:7.06亿   总股本:8.83亿

翰宇药业(300199)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.36亿元,每股收益-0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益73041.52万元,未分配利润-171868.48万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产311711.88万元,负债238670.36万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入375,225,390.5255,720,574.14150,256,744.79431,384,112.87
营业总成本459,578,775.38309,314,966.43156,147,173.76888,444,319.54
营业利润-26,228,246.69-2,716,192.76-4,914,615.8-507,504,657.44
利润总额-27,593,945.61-3,817,360.58-9,599,404.04-511,103,321.75
净利润-35,828,756.23-10,971,389.79-14,350,051.02-515,442,795.18
其他综合收益-713,914.14644,068.57238,209.621,771,775.42
综合收益总额-36,542,670.37-10,327,321.22-14,111,841.4-513,671,019.76
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计548,032,020.7452,438,180.12421,066,834.23683,638,339.56
非流动资产合计2,569,086,743.842,577,364,643.312,569,613,419.632,593,555,372
资产总计3,117,118,764.543,029,802,823.432,990,680,253.863,277,193,711.56
流动负债合计1,285,645,1191,072,981,322.351,028,243,878.091,423,438,972.66
非流动负债合计1,101,058,449.871,176,843,372.061,188,188,239.321,070,543,463.04
负债合计2,386,703,568.872,249,824,694.412,216,432,117.412,493,982,435.7
归属于母公司股东权益合计706,930,696.43754,040,259.98747,945,718.54758,803,660.3
股东权益合计730,415,195.67779,978,129.02774,248,136.45783,211,275.86
负债和股东权益合计3,117,118,764.543,029,802,823.432,990,680,253.863,277,193,711.56
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计501,843,341.73305,983,944.77156,972,689.61664,658,551.17
经营活动现金流出小计413,773,728.7272,999,341.68141,820,096.7668,195,124.68
经营活动产生的现金流量净额88,069,613.0332,984,603.0915,152,592.91-3,536,573.51
投资活动现金流入小计46,140,700.2446,040,700.241,040,700.24229,623,352.25
投资活动现金流出小计74,866,778.3246,709,614.2117,451,511.1681,912,593.16
投资活动产生的现金流量净额-28,726,078.08-668,913.97-16,410,810.92147,710,759.09
筹资活动现金流入小计1,241,333,185.23844,905,092.88315,765,898.811,389,708,470.8
筹资活动现金流出小计1,507,182,727.291,151,507,496.64614,769,056.281,293,862,954.31
筹资活动产生的现金流量净额-265,849,542.06-306,602,403.76-299,003,157.4795,845,516.49
汇率变动对现金及现金等价物的影响1,998,721.311,889,111.81412,506.77923,275.08
现金及现金等价物净增加额-204,507,285.8-272,397,602.83-299,848,868.71240,942,977.15
期末现金及现金等价物余额135,428,940.6467,538,623.6140,087,357.73339,936,226.44
最新报告期:2025-03-27
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
方正证券周超泽-0.200.450.682025-03-27
TOP↑